Nurse-coordinated care in CKD: time for translation into practice?

MeSH terms

• Biomarkers / blood
• Cardiovascular Agents / therapeutic use
• Cardiovascular Diseases / etiology
• Cardiovascular Diseases / prevention & control
• Chronic Disease
• Cost-Benefit Analysis
• Creatinine / blood
• Disease Progression
• General Practice / economics
• General Practice / organization & administration*
• Glomerular Filtration Rate
• Health Care Costs
• Hematinics / therapeutic use
• Humans
• Hypoglycemic Agents / therapeutic use
• Hypolipidemic Agents / therapeutic use
• Kidney / physiopathology*
• Kidney Diseases / complications
• Kidney Diseases / diagnosis
• Kidney Diseases / economics
• Kidney Diseases / nursing
• Kidney Diseases / physiopathology
• Kidney Diseases / therapy*
• Nurse Clinicians / economics
• Nurse Clinicians / organization & administration*
• Patient Care Team / economics
• Patient Care Team / organization & administration*
• Platelet Aggregation Inhibitors / therapeutic use
• Preventive Health Services / economics
• Preventive Health Services / organization & administration*
• Risk Assessment
• Risk Factors
• Risk Reduction Behavior
• Severity of Illness Index
• Smoking Cessation
• Treatment Outcome
• Up-Regulation